Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

Summary by defenseworld.net
Equities researchers at StockNews.com initiated coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the stock. Several other equities research analysts have also recently weighed in on EKSO. HC Wainwright reiterated a “buy” rating and issued a $9.00 target price on shares of Ekso Bionics in a report on Tuesday, January 14th. Lake Street Capital cut their …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal